查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613333

皮肤丝状菌症病药物市场：按治疗方法、产品和销售管道- 全球预测 2025-2030 年

Dermatophytosis Treatment Market by Treatment (Combination Therapies, Oral Antifungals, Topical Antifungals), Product (Over-the-Counter (OTC) Drugs, Prescription Drugs), Sales Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年皮肤丝状菌症治疗市场价值为126.3亿美元，预计2024年将达到133.3亿美元，复合年增长率为5.88%，到2030年将达到188.5亿美元，预计将达到1000万美元。

皮肤丝状菌症病药物是全球医疗保健市场的重要组成部分，用于治疗影响皮肤、头髮和指甲的真菌感染疾病。该市场包括各种局部和全身抗真菌药物，以及雷射治疗和新兴生物技术解决方案等新颖的治疗方法。这些治疗的需求是由于病菌感染在世界范围内广泛爆发，而潮湿的环境、卫生条件差和免疫力缺乏的个体数量不断增加等因素加剧了这种感染。这些疗法的应用涵盖非处方药和处方笺产品，并满足世界各地不同的消费者需求和医疗保健政策。最终用途范围包括医院、零售药局和线上平台，反映了广泛而多样化的市场范围。影响该市场的主要成长要素包括配方的进步、皮肤健康意识的提高以及可支配收入的增加以促进获得医疗保健。此外，专注于提高治疗效果和最大限度减少副作用的研发活动的活性化也带来了巨大的机会。公司可以透过投资技术创新和形成策略联盟来扩大产品系列和地理影响力来利用这些优势。然而，抗药性、现有治疗方法的潜在副作用以及严格的监管环境等限制带来了显着的挑战。新兴市场的经济障碍以及来自替代疗法和传统治疗方法的竞争进一步限制了市场扩张。需要创新的领域包括开发生物基抗真菌剂、动态疗法以及使用基因分析来提高治疗精度的个人化医疗方法。市场动态是一个充满活力的市场，其特点是快速的技术进步和不断变化的消费者需求，凸显了持续研究和敏捷业务策略的重要性。对于希望实现飞跃的公司来说，继续专注于永续的、以患者为中心的治疗解决方案至关重要。

主要市场统计
基准年[2023] 126.3亿美元
预计年份 [2024] 133.3亿美元
预测年份 [2030] 188.5亿美元
复合年增长率（%） 5.88%

市场动态：快速发展的皮肤丝状菌症药物市场的关键市场洞察

供需的动态交互作用正在改变皮肤丝状菌症病药物市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 香港脚在人群中的盛行率很高
    • 人们对皮肤丝状菌症的认识不断提高
  • 市场限制因素
    • 与产品召回相关的重大问题
  • 市场机会
    • 新型抗霉菌药物及新剂型研究进展
    • 透过线上销售管道扩大非处方皮肤科产品的供应
  • 市场挑战
    • 资本集中且耗时的产品核可流程

波特五力：驾驭皮肤丝状菌症药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解皮肤丝状菌症药物市场的外部影响

外部宏观环境因素在塑造皮肤丝状菌症治疗药物市场的表现动态中发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解皮肤丝状菌症治疗药物市场的竞争状况

对皮肤丝状菌症治疗药物市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵皮皮肤丝状菌症治疗市场供应商的绩效评估

FPNV定位矩阵是评估皮肤丝状菌症治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘皮肤丝状菌症治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对皮肤丝状菌症治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中香港脚盛行率高
      • 人们对皮肤丝状菌症的认识不断提高
    • 抑制因素
      • 与产品召回相关的严重问题
    • 机会
      • 研究重点是新型抗真菌药物和新製剂
      • 透过线上销售管道增加非处方皮肤科产品的供应
    • 任务
      • 资本集中且耗时的产品核可流程
  • 市场区隔分析

第 5 章 2.1。

第 5 章 2.2.销售管道：

  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依治疗分類的皮肤丝状菌症病药物市场

  • 联合治疗
  • 口服抗真菌药物
  • 局部抗真菌药物
    • 霜和乳液
    • 凝胶
    • 粉末
    • 喷

第七章皮肤丝状菌症治疗药物市场：副产品

  • 非处方药 (OTC)
  • 处方药

第八章皮肤丝状菌症治疗药物市场：依销售管道

  • 离线
    • 医院/诊所
    • 零售药房
  • 在线的

第九章北美及南美皮皮肤丝状菌症病治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太皮皮肤丝状菌症治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲皮皮肤丝状菌症治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 拜耳加强 Canesten 产品系列，以改善印度真菌感染疾病的治疗
    • Glenmark Pharmaceuticals 与 IADVL 合作推出「Hello Skin」聊天机器人，以对抗印度的皮肤丝状菌症
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Aetna Inc
  • Alva-Amco Pharmacal Companies, Inc
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd.
  • Cipla Ltd.
  • Creative Biolabs
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Ipca Laboratories Ltd
  • Leeford Healthcare Ltd
  • Mylan NV
  • Novartis AG
  • Oaknet Healthcare Pvt Ltd
  • Perrigo Company PLC
  • ProFoot, Inc.
  • Quinnova Pharmaceuticals Inc.
  • Sebela Pharmaceuticals Holdings Inc.
  • Steris Healthcare PVT Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Vibcare Pharma Pvt. Ltd.
Product Code: MRR-7A22CB0E5C75

The Dermatophytosis Treatment Market was valued at USD 12.63 billion in 2023, expected to reach USD 13.33 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 18.85 billion by 2030.

Dermatophytosis treatment is an imperative segment within the global healthcare market, addressing fungal infections affecting skin, hair, and nails. The scope of this market includes a wide range of topical and systemic antifungal medications and novel therapeutic approaches such as laser therapy and emerging biotech solutions. The necessity for these treatments stems from the widespread occurrence of dermatophytic infections globally, exacerbated by factors like humid environments, poor hygiene, and increasing rates of immunocompromised individuals. Applications of these treatments span across both over-the-counter and prescription-based products, catering to diverse consumer needs and healthcare policies worldwide. The end-use scope includes hospitals, retail pharmacies, and online platforms, reflecting a broad and versatile market reach. Key growth factors influencing this market include advancements in drug formulations, a rise in awareness about skin health, and an increase in disposable income facilitating access to healthcare. Moreover, heightened research and development activities, focused on enhancing treatment efficacy and minimizing side effects, present vital opportunities. Companies could capitalize on these by investing in innovation and forming strategic alliances to expand their product portfolio and geographical presence. However, limitations such as drug resistance, potential side effects of existing treatments, and stringent regulatory landscapes pose notable challenges. Economic barriers in developing regions further restrict market expansion, along with competition from alternative medicine and traditional remedies. Areas ripe for innovation include the development of bio-based antifungal agents, photodynamic therapy, and personalized medicine approaches using genetic profiling to enhance treatment precision. The nature of the dermatophytosis treatment market is dynamic, characterized by rapid technological advancements and evolving consumer needs, emphasizing the importance of continuous research and agile business strategies. For businesses looking to make significant strides, maintaining a focus on sustainable and patient-centric treatment solutions will be crucial.

KEY MARKET STATISTICS
Base Year [2023] USD 12.63 billion
Estimated Year [2024] USD 13.33 billion
Forecast Year [2030] USD 18.85 billion
CAGR (%) 5.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant prevalence of tinea pedis among the population
    • Growing awareness about dermatophytosis disorders
  • Market Restraints
    • Considerable issues associated with product recall
  • Market Opportunities
    • Research focused on new antifungal agents and new formulations
    • Growing availability of OTC dermatological products through online sales channels
  • Market Challenges
    • Capital-intensive and time-consuming product approval process

Porter's Five Forces: A Strategic Tool for Navigating the Dermatophytosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dermatophytosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dermatophytosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dermatophytosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dermatophytosis Treatment Market

A detailed market share analysis in the Dermatophytosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dermatophytosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dermatophytosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dermatophytosis Treatment Market

A strategic analysis of the Dermatophytosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatophytosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc, Alva-Amco Pharmacal Companies, Inc, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Blueberry Therapeutics Ltd., Cipla Ltd., Creative Biolabs, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Ipca Laboratories Ltd, Leeford Healthcare Ltd, Mylan N.V., Novartis AG, Oaknet Healthcare Pvt Ltd, Perrigo Company PLC, ProFoot, Inc., Quinnova Pharmaceuticals Inc., Sebela Pharmaceuticals Holdings Inc., Steris Healthcare PVT Ltd, Sun Pharmaceutical Industries Ltd., Taisho Pharmaceutical Co., Ltd., and Vibcare Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Dermatophytosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Combination Therapies, Oral Antifungals, and Topical Antifungals. The Topical Antifungals is further studied across Cream & Lotion, Gel, Powder, and Spray.
  • Based on Product, market is studied across Over-the-Counter (OTC) Drugs and Prescription Drugs.
  • Based on Sales Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant prevalence of tinea pedis among the population
      • 5.1.1.2. Growing awareness about dermatophytosis disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Considerable issues associated with product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Research focused on new antifungal agents and new formulations
      • 5.1.3.2. Growing availability of OTC dermatological products through online sales channels
    • 5.1.4. Challenges
      • 5.1.4.1. Capital-intensive and time-consuming product approval process
  • 5.2. Market Segmentation Analysis

5.2.1. Treatment:

5.2.2. Sales Channel:

  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dermatophytosis Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Combination Therapies
  • 6.3. Oral Antifungals
  • 6.4. Topical Antifungals
    • 6.4.1. Cream & Lotion
    • 6.4.2. Gel
    • 6.4.3. Powder
    • 6.4.4. Spray

7. Dermatophytosis Treatment Market, by Product

  • 7.1. Introduction
  • 7.2. Over-the-Counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. Dermatophytosis Treatment Market, by Sales Channel

  • 8.1. Introduction
  • 8.2. Offline
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Retail Pharmacies
  • 8.3. Online

9. Americas Dermatophytosis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Dermatophytosis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Dermatophytosis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Bayer Elevates Fungal Infection Treatment in India with Enhanced Canesten Range
    • 12.3.2. Glenmark Pharmaceuticals Launches 'Hello Skin' Chatbot in Collaboration with IADVL to Combat Dermatophytosis in India
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aetna Inc
  • 3. Alva-Amco Pharmacal Companies, Inc
  • 4. Aurobindo Pharma Limited
  • 5. Bausch Health Companies Inc.
  • 6. Bayer AG
  • 7. Blueberry Therapeutics Ltd.
  • 8. Cipla Ltd.
  • 9. Creative Biolabs
  • 10. Dr. Reddy's Laboratories Ltd.
  • 11. GlaxoSmithKline PLC
  • 12. Glenmark Pharmaceuticals Limited
  • 13. Ipca Laboratories Ltd
  • 14. Leeford Healthcare Ltd
  • 15. Mylan N.V.
  • 16. Novartis AG
  • 17. Oaknet Healthcare Pvt Ltd
  • 18. Perrigo Company PLC
  • 19. ProFoot, Inc.
  • 20. Quinnova Pharmaceuticals Inc.
  • 21. Sebela Pharmaceuticals Holdings Inc.
  • 22. Steris Healthcare PVT Ltd
  • 23. Sun Pharmaceutical Industries Ltd.
  • 24. Taisho Pharmaceutical Co., Ltd.
  • 25. Vibcare Pharma Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. DERMATOPHYTOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DERMATOPHYTOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DERMATOPHYTOSIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ORAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY CREAM & LOTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 234. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023